AngioDynamics (ANGO) to Release Quarterly Earnings on Tuesday

AngioDynamics (NASDAQ:ANGO - Get Free Report) is anticipated to release its Q4 2025 earnings data before the market opens on Tuesday, July 15th. Analysts expect the company to announce earnings of ($0.13) per share and revenue of $74.26 million for the quarter.

AngioDynamics Price Performance

Shares of AngioDynamics stock traded down $0.16 on Friday, reaching $9.32. The company had a trading volume of 388,725 shares, compared to its average volume of 583,202. The firm's 50-day moving average price is $9.87 and its two-hundred day moving average price is $10.07. AngioDynamics has a 1 year low of $5.67 and a 1 year high of $13.50. The firm has a market cap of $378.46 million, a price-to-earnings ratio of -9.23 and a beta of 0.60.

Institutional Trading of AngioDynamics

An institutional investor recently raised its position in AngioDynamics stock. Jane Street Group LLC lifted its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 267.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 46,803 shares of the medical instruments supplier's stock after buying an additional 34,054 shares during the quarter. Jane Street Group LLC owned approximately 0.12% of AngioDynamics worth $439,000 at the end of the most recent reporting period. 89.43% of the stock is owned by institutional investors.

Analyst Ratings Changes

Separately, HC Wainwright restated a "buy" rating and issued a $16.00 target price (up previously from $15.00) on shares of AngioDynamics in a report on Monday, April 7th.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.